Tag: CAR-T Cell Therapy

May 16, 2019

Biocure Enters into Exclusive Joint R&D Agreement with Pharos Vaccine Inc. for Overseas Market of CAR T-Cell Products

Biocure Technology Inc. (CSE:CURE) (OTCQB: BICTF) (formerly Gravis Energy Corp.) (the "Company" or "Biocure") is pleased to announce that Biocure...
March 14, 2019

Biocure Announces the Appointment of a New Director

Biocure Technology Inc. (CSE:CURE) (OTC:BICTF) ("CURE" or the "Company") is pleased to announce that effective of today's date, Mr. Danny Joh...
February 28, 2019

BiocurePharm, Korea (“BPK”) Announces Closing of Private Placement

Biocure Technology Corp. (CSE:CURE) (OTC:BICTF) ("CURE" or the "Company") BiocurePharm, Korea ("BPK"), a wholly owned subsidiary of Biocure Technology Inc....
February 19, 2019

Biocure Technology Corp Announces a MOU with the Government of Uzbekistan and Gold-Dream LLC to Build a Manufacturing Plant to Produce Biosimilars

Biocure Technology Corp. (CSE:CURE) (OTC:BICTF) ("CURE" or the "Company") BiocurePharm, Korea ("BPK"), a wholly owned subsidiary of Biocure Technology Inc. ("CURE") has entered...
February 14, 2019

Biocure Technology Inc. Announces Private Placement

Biocure Technology Inc. (CSE:CURE, OTCQB:BICTF) ("CURE" or the "Company") is pleased to announce that it has arranged a non-brokered private placement...
February 7, 2019

Biocure Shares DTC Eligible

Biocure Technology Inc. (CSE:CURE, OTCQB:BICTF)("CURE" or the "Company") is pleased to announce that its OTCQB-listed common shares are now eligible for electronic...
January 14, 2019

Biocure Signs a Collaboration Agreement with Y Biologics

Biocure Technology Inc. (CSE:CURE, OTCQB:BICTF) (the "Company" or "Biocure") BiocurePharm, Korea ("BPK"), a wholly owned subsidiary of Biocure Technology Inc....